Skip to main content
. 2025 Oct 20;27:e63350. doi: 10.2196/63350

Table 4. Changes in blood pressure, medication, and lifestyle factors among participants at 1-year follow-up visit.

Lifestyle change Remote patient management (n=1021) Usual care (n=1017) P value
Current smokinga, n (%) 114 (11.2) 142 (14.0) .06
Current drinkingb, n (%) 119 (11.7) 168 (16.5) .002
Blood pressure control achieved
 Blood pressure(mmHg), mean (SD)
  Systolic 117.74 (13.80) 121.46 (16.85) .002
  Diastolic 73.60 (10.18) 75.72 (10.45) .02
 Distribution of BP, n (%)
  Proportion of patients with BP
  >140/90 mmHg 123 (12.0) 188 (18.5) <.001
  Proportion of patients with BP
  >130/80 mmHg 310 (30.4) 442 (43.5) <.001
Medication adherencec, n (%)
 Aspirin 896 (87.8) 858 (84.4) .03
 P2Y12 antagonists 847 (83.0) 812 (79.8) .07
 Statins 810 (79.3) 776 (76.3) .10
 ACEId/ARBe/ARNIf 489 (47.9) 442 (43.5) .045
 Beta-blockers 533 (52.2) 516 (50.7) .51
a

Current smokers were defined as those who smoked at least one cigarette per day.

b

Current drinkers were defined as those who drank alcohol at least twice a week for ≥4 consecutive weeks.

c

Adherence was defined as having medication available to take on ≥80% of the days during the follow-up period (ie, Proportion of Days Covered ≥80%). The Proportion of Days Covered (PDC) for each medication was calculated as the days covered by filled prescriptions divided by the follow-up period from discharge to the last interview, unless therapy was discontinued for ≥3 months. Discontinued medications and approximate discontinuation dates were recorded through interviews and clinical records review.

d

ACEI: angiotensin-converting enzyme inhibitor.

e

ARB: angiotensin II receptor blocker.

f

ARNI: angiotensin receptor neprilysin inhibitor.